real-world evidence confirms that AVISE testing enables decisive clinical action superior to the current standard of care
Tuesday, August 20, 2024 1 min read
Key Takeaway: The article discusses the confirmation of real-world evidence regarding AVISE testing. It highlights that this testing enables clinical actions that are superior to the current standard of care. However, the article lacks specific details or data to support these claims.
Price reaction · baseline $3.2 (2024-08-19 close) · hit pre-market · clean, no other XGN news in the window